| Financial Year |
March 31 2023 |
| Monetary Funds |
69,502,120.44 |
| Held-for-trading Financial Assets |
191,761,930.73 |
| Notes Receivable |
6,685,387.25 |
| Accounts Receivable |
305,033,295.48 |
| Advances to Suppliers |
1,582,505.77 |
| Other Receivables |
5,442,180.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,552,432.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
665,361.77 |
| Other Current Assets |
13,467,490.67 |
| Total Current Assets |
707,060,973.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,287,741.62 |
| Long-term Equity Investment |
-- |
| Investment Properties |
15,082,143.86 |
| Fixed Assetes |
95,345,449.09 |
| Under-construction Projects |
2,128,869.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,255,510.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,029,879.52 |
| Deferred Income Tax Assets |
6,729,393.33 |
| Other Non-Current Assets |
4,745,853.82 |
| Sub-Total of Non-Current Assets |
186,384,657.49 |
| Total Assets |
893,445,630.96 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,833,345.74 |
| Accounts Payable |
194,402,791.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,460,926.68 |
| Taxes Payable |
10,515,451.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,489,104.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,395,593.27 |
| Other Current Liabilities |
27,719.91 |
| Sub-Total of Current Liabilities |
265,409,723.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
842,607.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,167,460.46 |
| Total Liabilities |
304,577,183.72 |
| Paid-In Capital(Or Share Stock) |
189,947,200.00 |
| Capital Surplus |
186,890,479.27 |
| Surplus Reserve |
30,961,825.29 |
| LESS:Treasury Stock |
3,985,800.00 |
| Undistributed Profits |
167,126,326.62 |
| Minority Stockholder's Interest |
16,316,056.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
572,552,390.92 |
| Owner's Equity（Stockholder's Equity） |
588,868,447.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
893,445,630.96 |
